Immunohistochemical analyses of primary NSCLC tissues showed that C/EBPβ expression was already enhanced from the early stages of lung cancer but there were no significant differences among different clinical stages, tumor, node, metastasis (TNM) stage, age, or sex (Table 2). Here, CEBPB is linked to neoplasm.